{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:08:46Z","timestamp":1789564126729,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jvascsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jvs.2024.09.008","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T12:45:13Z","timestamp":1726749913000},"page":"229-234.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are associated with improved amputation-free survival in chronic limb-threatening ischemia"],"prefix":"10.1016","volume":"81","author":[{"given":"Nadin","family":"Elsayed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina L.","family":"Straus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darrin","family":"Clouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9399-2832","authenticated-orcid":false,"given":"Raghu L.","family":"Motaganahalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Malas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvs.2024.09.008_bib1","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.jvs.2015.07.065","article-title":"The natural history of untreated severe or critical limb ischemia","volume":"62","author":"Abu Dabrh","year":"2015","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2024.09.008_bib2","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jvs.2009.08.073","article-title":"Critical limb ischemia","volume":"51","author":"Varu","year":"2010","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2024.09.008_bib3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients","volume":"342","author":"Yusuf","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2024.09.008_bib4","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.diabres.2013.12.060","article-title":"Effectiveness of combined therapy with angiotensin-converting enzyme inhibitors and statins in reducing mortality in diabetic patients with critical limb ischemia: an observational study","volume":"103","author":"Faglia","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jvs.2024.09.008_bib5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/1358863X15574321","article-title":"Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use is associated with reduced major adverse cardiovascular events among patients with critical limb ischemia","volume":"20","author":"Armstrong","year":"2015","journal-title":"Vasc Med"},{"key":"10.1016\/j.jvs.2024.09.008_bib6","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.jvs.2017.07.130","article-title":"Long-term mortality benefit of renin-angiotensin system inhibitors in patients with chronic limb-threatening ischemia undergoing vascular intervention","volume":"67","author":"Bodewes","year":"2018","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2024.09.008_bib7","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1016\/j.jvs.2021.06.376","article-title":"Continuous ACE inhibitor use is associated with improved perioperative and long-term mortality benefit in patients undergoing lower extremity bypass for peripheral arterial disease","volume":"74","author":"Naazie","year":"2021","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2024.09.008_bib8","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.avsg.2022.07.022","article-title":"Association of renin-angiotensin-aldosterone system inhibitor usage patterns with midterm amputation-free survival after lower extremity bypass for peripheral arterial disease","volume":"88","author":"Naazie","year":"2023","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jvs.2024.09.008_bib9","author":"Telmisartan"},{"key":"10.1016\/j.jvs.2024.09.008_bib10","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)","volume":"288","year":"2002","journal-title":"JAMA, J Am Med Assoc"},{"key":"10.1016\/j.jvs.2024.09.008_bib11","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.jacc.2016.11.008","article-title":"2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary","volume":"69","author":"Gerhard -Herman","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2024.09.008_bib12","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1001\/jama.2012.216237","article-title":"Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial","volume":"309","author":"Ahimastos","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jvs.2024.09.008_bib13","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.jvs.2012.03.016","article-title":"The society for Vascular Surgery Vascular Quality initiative","volume":"55","author":"Cronenwett","year":"2012","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2024.09.008_bib14","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1016\/j.jvs.2020.04.507","article-title":"The vascular implant surveillance and interventional outcomes (VISION) coordinated registry Network: an effort to advance evidence evaluation for vascular devices","volume":"72","author":"Tsougranis","year":"2020","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2024.09.008_bib15","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.jvs.2016.12.100","article-title":"A\u00a0pilot study for long-term outcome assessment after aortic aneurysm repair using VQI data matched to Medicare claims","volume":"66","author":"Hoel","year":"2017","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2024.09.008_bib16","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.jvs.2020.02.041","article-title":"Improved survival with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic limb-threatening ischemia","volume":"72","author":"Khan","year":"2020","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2024.09.008_bib17","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1161\/01.HYP.0000092440.52239.39","article-title":"Important role of nitric oxide in the effect of angiotensin-converting enzyme inhibitor imidapril on vascular injury","volume":"42","author":"Chen","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.jvs.2024.09.008_bib18","first-page":"1","article-title":"Cardiovascular risk reduction by reversing endothelial dysfunction: ARBs, ACE inhibitors, or both? Expectations from The ONTARGET Trial Programme","volume":"3","author":"Ruilope","year":"2007","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.jvs.2024.09.008_bib19","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s11886-012-0275-9","article-title":"Effect of Angiotensin-converting enzyme inhibitors and Angiotensin receptor antagonists in atherosclerosis prevention","volume":"14","author":"Patarroyo","year":"2012","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.jvs.2024.09.008_bib20","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.atherosclerosis.2011.12.005","article-title":"Angiotensin converting enzyme inhibitors effect on arterial stiffness and wave reflections: a meta-analysis and meta-regression of randomised controlled trials","volume":"221","author":"Shahin","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jvs.2024.09.008_bib21","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/bjs.9198","article-title":"Randomized clinical trial of angiotensin-converting enzyme inhibitor, ramipril, in patients with intermittent claudication","volume":"100","author":"Shahin","year":"2013","journal-title":"Br J Surg"},{"key":"10.1016\/j.jvs.2024.09.008_bib22","first-page":"22","article-title":"The effect of enalapril on leg muscle blood flow in patients with claudication","volume":"9","author":"Sonecha","year":"1990","journal-title":"Int Angiol"},{"key":"10.1016\/j.jvs.2024.09.008_bib23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.atherosclerosis.2011.02.044","article-title":"Angiotensin converting enzyme inhibitors effect on endothelial dysfunction: a meta-analysis of randomised controlled trials","volume":"216","author":"Shahin","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jvs.2024.09.008_bib24","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1016\/j.jcin.2020.08.036","article-title":"Predictors of underutilization of medical therapy in patients undergoing endovascular revascularization for peripheral artery disease","volume":"13","author":"Altin","year":"2020","journal-title":"JACC Cardiovasc Interv"}],"container-title":["Journal of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521424018871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521424018871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T06:11:30Z","timestamp":1733897490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0741521424018871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0741521424018871"],"URL":"https:\/\/doi.org\/10.1016\/j.jvs.2024.09.008","relation":{},"ISSN":["0741-5214"],"issn-type":[{"value":"0741-5214","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are associated with improved amputation-free survival in chronic limb-threatening ischemia","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvs.2024.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the Society for Vascular Surgery.","name":"copyright","label":"Copyright"}]}}